20.06
price up icon2.40%   0.47
after-market Handel nachbörslich: 20.05 -0.010 -0.05%
loading
Schlusskurs vom Vortag:
$19.59
Offen:
$19.61
24-Stunden-Volumen:
192.12K
Relative Volume:
0.98
Marktkapitalisierung:
$358.52M
Einnahmen:
$116.88M
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-143.29
EPS:
-0.14
Netto-Cashflow:
$-20.74M
1W Leistung:
+6.14%
1M Leistung:
+5.97%
6M Leistung:
-8.02%
1J Leistung:
+98.42%
1-Tages-Spanne:
Value
$19.43
$20.29
1-Wochen-Bereich:
Value
$18.66
$20.29
52-Wochen-Spanne:
Value
$8.61
$29.82

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
Firmenname
Rigel Pharmaceuticals
Name
Telefon
650-624-1100
Name
Adresse
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
164
Name
Twitter
@rigelpharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
RIGL's Discussions on Twitter

Vergleichen Sie RIGL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RIGL
Rigel Pharmaceuticals
20.06 337.79M 116.88M -25.09M -20.74M -0.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-04-03 Fortgesetzt Piper Sandler Neutral
2022-06-09 Herabstufung Citigroup Buy → Neutral
2022-06-08 Herabstufung Cantor Fitzgerald Overweight → Neutral
2022-06-08 Herabstufung Piper Sandler Overweight → Neutral
2022-03-23 Eingeleitet B. Riley Securities Neutral
2020-11-09 Herabstufung JP Morgan Overweight → Neutral
2019-11-15 Fortgesetzt Cantor Fitzgerald Overweight
2019-09-26 Fortgesetzt JP Morgan Overweight
2019-03-01 Bestätigt Cantor Fitzgerald Overweight
2018-08-27 Eingeleitet Citigroup Buy
2018-05-02 Bestätigt Cantor Fitzgerald Overweight
2017-12-21 Fortgesetzt Piper Jaffray Overweight
2017-12-15 Eingeleitet Cantor Fitzgerald Overweight
2017-11-06 Fortgesetzt H.C. Wainwright Buy
2017-03-09 Bestätigt H.C. Wainwright Buy
2016-08-31 Bestätigt H.C. Wainwright Buy
2016-08-30 Bestätigt Piper Jaffray Overweight
2016-07-13 Eingeleitet H.C. Wainwright Buy
2016-06-13 Eingeleitet Piper Jaffray Overweight
2016-04-22 Hochstufung JP Morgan Neutral → Overweight
2013-04-08 Bestätigt Stifel Buy
2012-11-29 Eingeleitet UBS Neutral
2012-11-06 Bestätigt Oppenheimer Outperform
2012-03-26 Eingeleitet Canaccord Genuity Hold
2010-12-10 Herabstufung MP Advisors Outperform → Market Perform
Alle ansehen

Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten

pulisher
07:47 AM

What analysts say about Rigel Pharmaceuticals Inc. stockHigh-impact stock picks - jammulinksnews.com

07:47 AM
pulisher
03:41 AM

Is Rigel Pharmaceuticals Inc. a good long term investmentOutstanding yields - jammulinksnews.com

03:41 AM
pulisher
Jul 20, 2025

(RIGL) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Rigel Pharmaceuticals Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Rigel Pharmaceuticals Inc. stock priceTriple-digit returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 15, 2025

What makes Rigel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

Why Rigel Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Insider Monkey

Jul 10, 2025
pulisher
Jul 10, 2025

(RIGL) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | RIGL Stock News - GuruFocus

Jul 07, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - 富途牛牛

Jul 07, 2025
pulisher
Jun 18, 2025

Recent 11% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 112% over 1 year - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Canada

Jun 14, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com

Jun 14, 2025
pulisher
Jun 11, 2025

High-grade Glioma Market Expected to Experience Major Growth by 2034, According to DelveInsight | Rigel Pharma, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Rigel Pharma To Present At Jefferies Global Healthcare Conference; Webcast At 12:50 PM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Increases Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Rigel to Present at the Jefferies Global Healthcare Conference - StreetInsider

May 29, 2025
pulisher
May 28, 2025

Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise

May 28, 2025
pulisher
May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference | RIGL Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference – Company Announcement - Financial Times

May 28, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India

May 26, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com

May 26, 2025
pulisher
May 25, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World

May 25, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 25, 2025
pulisher
May 23, 2025

Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks

May 23, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire

May 22, 2025
pulisher
May 22, 2025

Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 22, 2025

Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):